Alemtuzumab treatment in Multiple Sclerosis: real clinical experience in the Northwest of Spain

被引：0

作者：

Lopez Real, Ana ^{[1
]}

Gonzalez Suarez, Ines ^{[2
]}

Costa Arpin, Eva ^{[3
]}

Pato Pato, Antonio ^{[4
]}

Alvarez Rodriguez, Elena ^{[2
]}

Rodriguez Regal, Ana ^{[5
]}

Garcia-Pelayo Rodriguez, Ana ^{[1
]}

Garcia Bargo, Maria Dolores ^{[6
]}

Llaneza Gonzalez, Miguel ^{[7
]}

Rodriguez Rodriguez, Maria ^{[8
]}

Solar Sanchez, Dulce Maria ^{[9
]}

Oterino Duran, Agustin ^{[10
]}

Pena Martinez, Joaquin ^{[11
]}

机构：

[1] Univ Hosp A Coruna, Neurol, La Coruna, Spain

[2] Univ Hosp Vigo, Neurol, Vigo, Spain

[3] Univ Hosp Santiago De Compostela, Neurol, Santiago De Compostela, Spain

[4] Povisa Hosp Vigo, Neurol, Vigo, Spain

[5] Univ Hosp Pontevedra, Neurol, Pontevedra, Spain

[6] Univ Hosp Ourense, Neurol, Orense, Spain

[7] Univ Hosp Ferrol, Neurol, Ferrol, Spain

[8] Hosp Lucus Augusti, Lugo, Spain

[9] Univ Hosp Cabuenes, Neurol, Gijon, Spain

[10] Univ Hosp Marques Valdecilla, Neurol, Santander, Spain

[11] Univ Hosp San Agustin, Neurol, Aviles, Spain

来源：

NEUROLOGY | 2018年 / 90卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P6.352

引用

页数：3

共 50 条

[21] Preclinical and clinical evaluation of alemtuzumab in multiple sclerosis
Siders, William
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[22] Sarcoidosis following alemtuzumab treatment for multiple sclerosis
Willis, Mark D.
Hope-Gill, Ben
Flood-Page, Patrick
Joseph, Fady
Needham, Ed
Jones, Joanne
Coles, Alasdair
Robertson, Neil P.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (13) : 1779 - 1782
[23] Natalizumab treatment in multiple sclerosis - an experience from Malaga, Spain
Papais Alvarenga, M.
Fernandez, V.
Guerrero, M.
Luque, G.
Oliver, B.
Leyva, L.
Fernandez, O.
MULTIPLE SCLEROSIS, 2009, 15 (09): : S233 - S233
[24] Cladribine as treatment of multiple sclerosis, real world experience
Celius, E. G.
Berg-Hansen, P.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 527 - 528
[25] Melanoma following treatment with alemtuzumab for multiple sclerosis
Pace, A. A.
Zajicek, J. P.
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (04) : E70 - E71
[26] EMA approves alemtuzumab for the treatment of multiple sclerosis
Wilkinson, Jonathan
IMMUNOTHERAPY, 2013, 5 (11) : 1166 - 1166
[27] SARCOIDOSIS FOLLOWING ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS
Willis, M. D.
May, K.
Hope-Gill, B.
Flood-Page, P.
Jeffrey, D.
Joseph, F.
Robertson, N. P.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A54 - A55
[28] Alemtuzumab: a further option for treatment of multiple sclerosis
Menge, T.
Kieseier, B. C.
Warnke, C.
Aktas, O.
Hartung, H. -P.
NERVENARZT, 2012, 83 (04): : 487 - 501
[29] Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use
Havrdova, Eva
Horakova, Dana
Kovarova, Ivana
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 31 - 45
[30] Long-term efficacy of alemtuzumab in multiple sclerosis: a real word multicenter Spanish experience
Rubio Alcantud, Almudena
Costa-Frossard, Lucienne
Valero Lopez, Gabriel
Alcala, Carmen
Garcia Dominguez, Jose Manuel
Gascon, Francisco
Navarro, Laura
Aguirre, Clara
Brieva Ruiz, Luis
Alvarez Bravo, Gary Ciceron
Fernandez Diaz, Eva
Valenzuela Rojas, Francisco Jose
Mallada, Javier
Castillo Trivino, Tamara
Berenguer, Leticia
Sabin Munoz, Julia
De Arcaya Esquide, Amaya Elena Alvarez
Carcelan Gadea, Maria Encarna
Landete, Lamberto
Villaverde, Ramon
Monreal, Enric
Meca Lallana, Jose
Eichau, Sara
Martinez Gines, Marisa Luisa
Meca, Virginia
Anna, Gil
Puig Casadevall, Marc
Palao Rico, Maria
Blasco Quilez, Rosario
Ramio-Torrenta, Lluis
Quintanilla Bordas, Carlos
Casanova, Bonaventura
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 355 - 356

← 1 2 3 4 5 →